UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Lansing Street Advisors

Lansing Street Advisors raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 766 shares of the healthcare conglomerate’s stock after buying an additional 27 shares during the period. Lansing Street Advisors’ holdings in UnitedHealth Group were worth $388,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $37,000. Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $55,000. Legacy Investment Solutions LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $57,000. Finally, DecisionPoint Financial LLC increased its stake in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on UNH. KeyCorp restated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Down 7.3 %

Shares of UnitedHealth Group stock opened at $465.58 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market cap of $428.46 billion, a P/E ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61. The stock’s 50 day simple moving average is $519.27 and its 200-day simple moving average is $560.48. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the firm posted $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.